Analysis of TERT association with clinical outcome in meningiomas: a multi-institutional cohort study.

Saved in:
Bibliographic Details
Title: Analysis of TERT association with clinical outcome in meningiomas: a multi-institutional cohort study.
Authors: Gui C; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Wang JZ; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Patil V; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Landry AP; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Singh O; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Castelo-Branco P; Faculty of Medicine and Biomedical Sciences, University of Algarve, Gambelas Campus, Faro, Portugal; Algarve Biomedical Center Research Institute (ABC-RI), University of Algarve, Gambelas Campus, Faro, Portugal; Champalimaud Research Program, Champalimaud Centre for the Unknown, Lisbon, Portugal., Tabori U; Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada., Aldape K; Laboratory of Pathology, National Cancer Institute Centre for Cancer Research, Bethesda, MD, USA., Behling F; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Barnholtz-Sloan JS; Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD, USA., Horbinski C; Department of Pathology, Northwestern University, Chicago, IL, USA; Lou & Jean Malnati Brain Tumor Institute at the Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Tabatabai G; German Cancer Consortium, DKFZ Partner Site Tübingen, Tübingen, Germany; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany., Ajisebutu A; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Liu J; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Patel Z; Temerty School of Medicine, University of Toronto, Toronto, ON, Canada., Yakubov R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Kaloti R; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Ellenbogen Y; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Wilson C; Oklahoma State University College of Osteopathic Medicine, Tulsa, OK, USA., Cohen-Gadol A; Department of Neurological Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA., Tatagiba M; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Holland EC; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Sloan AE; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Piedmont Brain Tumor Center, Piedmont Health, Atlanta, GA, USA., Chotai S; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA; Cleveland Clinic Foundation, Cleveland, OH, USA., Chambless LB; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA., Gao A; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Makarenko S; Division of Neurosurgery, University of British Columbia, Vancouver, BC, Canada., Yip S; Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Nassiri F; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Zadeh G; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address: gelareh.zadeh@uhn.ca.
Corporate Authors: International Consortium on Meningiomas (ICOM)
Source: The Lancet. Oncology [Lancet Oncol] 2025 Sep; Vol. 26 (9), pp. 1191-1203.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(25)00267-0